Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.
Paying user area
Try for free
Vertex Pharmaceuticals Inc. pages available for free this week:
- Common-Size Income Statement
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Common Stock Valuation Ratios
- Operating Profit Margin since 2005
- Debt to Equity since 2005
- Price to Earnings (P/E) since 2005
- Analysis of Revenues
- Analysis of Debt
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Vertex Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Vertex Pharmaceuticals Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)
US$ in thousands
Based on: 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
The financial data reveals several notable trends in the liabilities and equity components over the examined periods.
- Current Liabilities
-
Accounts payable demonstrated fluctuations with a general increasing trend, rising from approximately $100.7 million at the start to $445 million by the end of the period, with some interim volatility. Accrued expenses also showed a consistent upward movement from roughly $1.26 billion to about $2.95 billion, indicating growing short-term obligations. Other current liabilities experienced variability but trended upward substantially, peaking at around $648.6 million before moderating somewhat. Overall, current liabilities increased from $1.54 billion to $3.78 billion, reflecting rising short-term financial commitments.
- Long-term Liabilities
-
Long-term operating lease liabilities began being reported from December 2020, initially near $350 million, then exhibited a substantial jump in late 2024 to approximately $1.54 billion, suggesting new lease obligations or reclassifications. Long-term finance lease liabilities declined steadily from about $533 million to $111 million, indicating repayment or settlement of outstanding leases. Other long-term liabilities were variable but mostly increased, reaching near $952 million by the end. Total long-term liabilities demonstrated an increase from around $893 million to $2.60 billion, highlighting a strengthening in long-term obligations.
- Total Liabilities
-
Total liabilities showed a consistent upward trend from approximately $2.43 billion to about $6.38 billion over the timeframe, underscoring an overall rise in the company's obligations. This growth appears driven by both current and long-term liabilities, with marked increases in accrued expenses and lease liabilities contributing significantly.
- Shareholders’ Equity
-
Common stock remained stable around $2.6 million, indicating no significant new issuances or buybacks. Additional paid-in capital fluctuated, peaking near $7.4 billion before decreasing to approximately $6.17 billion, which could reflect share repurchases or other equity adjustments. Accumulated other comprehensive income/loss demonstrated volatility, swinging between gains and losses but showing a positive balance near $68 million at the end. Retained earnings increased substantially from a deficit of about $1.25 billion to a positive balance of over $10.25 billion, indicating sustained profitability or earnings retention. Shareholders’ equity grew overall from about $6.46 billion to approximately $16.50 billion, although a decline in mid-late 2024 suggests possible impacts on equity during that period.
- Overall Financial Position
-
Total liabilities and shareholders’ equity combined increased steadily, from roughly $8.89 billion to nearly $22.88 billion, reflecting growth in the company's capital base and obligations. Notably, the periods around late 2024 show some volatility, particularly in lease liabilities and equity components, which may warrant further investigation. The data suggests expanding operations or investments financed through increased liabilities and equity, with profitability contributing to growing retained earnings.